Research Article
Tryptophan-Kynurenine Metabolism and Insulin Resistance in Hepatitis C Patients
Table 1
Kynurenines and insulin resistance in intent-to-treatment HCV patients.
| | HOMA2-IR 1.3 (0.4–3.4)* | HOMA-beta 153 (57–395)* | KYN 1030 (480–3100)** | TRP 13550 (7000–27000)** | KTR 7.5 (3.2–14.2)* | KYNA 10 (4.3–36) |
| HOMA2-IR | |
|
|
| Not significant | Not significant | HOMA-beta |
| |
|
| Not significant | Not significant | KYN |
|
| |
|
|
| TRP |
|
|
| |
| Not significant | KTR | Not significant | Not significant |
|
| | Not significant | KYNA | Not significant | Not significant |
| Not significant | Not significant | |
|
|
Median (50th percentile) (minimum-maximum). pmol/mL (50th percentile) (minimum-maximum).
|